Valued at $346.5M at its later-stage round, Jan 2025. Nothing has traded since.
- ·The complete investor list: 13 names
- ·Watch Aviceda Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Aviceda Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2024 | Later Stage VC | $75.0M | ▮ | ▮ |
| May 2024 | Early Stage VC | $18.9M | ▮ | ▮ |
| May 2023 | Early Stage VC | $15.6M | ▮ | ▮ |
Membership and data by Private Market View
Aviceda Therapeutics valuation
Aviceda Therapeutics was valued at $347 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Aviceda Therapeutics raised?
Aviceda Therapeutics has raised $276 million in total; 3 of its rounds are on record, from 2023 on. The largest on record was a $75 million later-stage round in Nov 2024.
Aviceda Therapeutics has filed 4 Form Ds with the SEC since 2023, most recently in Jan 2025 ($75 million sold to 17 investors).
How Aviceda Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Aviceda Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Aviceda Therapeutics
- What is Aviceda Therapeutics worth?
- Aviceda Therapeutics is valued at $346.5M as of Oct 2026. Valued at $346.5M at its later-stage round, Jan 2025. Nothing has traded since.
- How much has Aviceda Therapeutics raised?
- Aviceda Therapeutics has raised $276.3M in total funding across 3 recorded rounds.
- When did Aviceda Therapeutics last raise?
- Aviceda Therapeutics last raised in Nov 2024 (Later Stage VC), raising $75.0M.